{
  "abstract": "Background and Importance Insulins are high-alert critical medicines which have been identified as a significant medication safety issue nationally and locally. Annual insulin audits have been conducted locally since 2022 to evaluate use and develop QI including the appointment of a diabetes pharmacist, updated insulin charts, a bespoke eLearning module for the safe use of insulin, and continuous education.Aim and Objectives To conduct a similar audit to assess performance and develop further QI as needed.Material and Methods This audit was conducted over one day in May 2025 using the SMART criteria, approved by the local Clinical Audit Committee, piloted, and communicated to 25 interprofessional data collectors. Generated data were anonymous and securely stored. Independent analysis was conducted by three researchers to confirm reliability of results.Results 575 inpatients were reviewed on 24 wards. 7% were prescribed insulin, 22% had an Insulin and Glucose Monitoring Record, and 18% had a documented history of diabetes of whom 36% were treated with insulin. 80% of inpatients on insulin were living with T2DM. Patient speciality comprised 74% medical and 26% surgical. Prescribing errors comprised 53% of records, a significant improvement from previous audits. >90% of prescribers clearly documented the correct insulin name, dose, and administration times; signed each prescription; and documented a medical council registration number, bleep, or name for contact purposes. Administration errors comprised 85% of records, similar to previous audits. 9% of insulin entries were administered when not prescribed, 11% were not double-checked, and 42% administration times were not documented. The diabetes team reviewed 62% inpatients on regular insulin. 38% inpatients had changes made to their insulin doses of whom 77% were reviewed by the diabetes team. 9% had a single omission of long-acting insulin (all with T2DM), 9% required the perioperative/fasting protocol which was followed correctly, and 9% had episodes of hypoglycaemia with no subsequent omission of insulin.Conclusion and Relevance Results were positive and an improvement from previous audits. QI include reviewing the current practice of prescribing insulin daily to a longer duration and the implementation of ePrescribing in the future. All Irish hospitals have been encouraged to conduct a standardised national annual insulin audit to optimise patient care.Conflict of Interest No conflict of interest",
  "authors": [
    {
      "affiliations": [
        "University Hospital Galway, Pharmacy Department, Co. Galway, Ireland Rep"
      ],
      "name": "D Hogan-Murphy"
    }
  ],
  "title": "5PSQ-050 Revisiting insulin prescribing, administration, and glucose monitoring practices in a hospital setting",
  "uid": "5ae04149-4a94-5e00-9cde-9fc32a0b8ee5"
}